Announcements Trials
Browse Landscape

Phase

Phase NA 72Phase 2 25Phase 1 18Phase 3 6Phase 1/2 6Phase 2/3 3Phase EARLY_PHASE1 2

Status

Completed 58Unknown 20Recruiting 16Active not recruiting 13Terminated 6Not yet recruiting 6Withdrawn 4Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 91Thoracic 54Breast 51Gynecologic 29Genitourinary 28Head & Neck 25Lymphoid 18Other hematologic neoplasm 16CNS 12Plasma cell 9Sarcoma 7Tumor-Agnostic 6Dermatologic 6Endocrine 4Myeloid 3Classical hematology 2Other solid neoplasm 1NET 1

Conditions

Neoplasms 3Adenocarcinoma 2Neoplasm Metastasis 1

Interventions

Oxaliplatin 3tislelizumab 1Standard of Care 1Radiotherapy 1Leucovorin 1Glutamine 1Fluorouracil 1Chemoradiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Tumor-Agnostic × Clear all
NCT07583979 2026-05-13

EAST-ALIGN

National Cancer Centre, Singapore

Phase 3 Not yet recruiting
168 enrolled
Tumor-Agnostic

Neoplasms

NCT07385703 2026-02-04

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Not yet recruiting
752 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT07287592 2025-12-17

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Ain Shams University

Phase 3 Not yet recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

NCT07118800 2025-08-12

NACRE-2

UNICANCER

Phase 3 Not yet recruiting
160 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
174 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT03961841 2019-12-23

Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Not yet recruiting
900 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡